Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | KDM6B | O15054 | 1/20 | 0.48 |
| ▸ | KDM5C | P41229 | 1/20 | 0.48 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.48 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.48 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2439884 | 1.00 | ALDH1A1 (0.77) | ALDH1A1LMNASLC15A2KDM4EKDM6B | |
| SCHEMBL28966701 | 0.96 | ALDH1A1 (0.71) | ALDH1A1LMNASLC15A2KDM4EKDM6B | |
| SCHEMBL11683116 | 0.90 | ALDH1A1 (0.62) | ALDH1A1LMNASLC15A2KDM4EKDM6B | |
| SCHEMBL10001 | 0.88 | — | — | |
| SCHEMBL23521340 | 0.87 | ALDH1A1 (0.59) | ALDH1A1LMNASLC15A2KDM4EKDM6B | |
| SCHEMBL18506612 | 0.87 | ALDH1A1 (0.59) | ALDH1A1LMNASLC15A2KDM4EKDM6B | |
| SCHEMBL16498015 | 0.87 | ALDH1A1 (0.59) | ALDH1A1LMNASLC15A2KDM4EKDM6B | |
| SCHEMBL22110900 | 0.87 | ALDH1A1 (0.59) | ALDH1A1LMNASLC15A2KDM4EKDM6B | |
| SCHEMBL21174517 | 0.87 | LMNA (0.82) | ALDH1A1LMNASLC15A2KDM4EKDM6B | |
| SCHEMBL4084926 | 0.87 | ALDH1A1 (0.59) | ALDH1A1LMNASLC15A2KDM4EKDM6B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030790-B2 | Method for removing fluorine-containing compound from waste water | DAIKIN INDUSTRIES, LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-11220571-B2 | Aqueous polyurethane dispersions | LAMBERTI SPA (IT) | 2022-01-11 | — | — | US | disclosed |
| EP-3666802-A1 | METHOD FOR PRODUCING PURIFIED POLYTETRAFLUOROETHYLENE AQUEOUS DISPERSION LIQUID, METHOD FOR PRODUCING MODIFIED POLYTETRAFLUOROETHYLENE POWDER, METHOD FOR PRODUCING POLYTETRAFLUOROETHYLENE MOLDED BODY, AND COMPOSITION | Daikin Industries, Ltd. (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-10370654-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180320170-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2018-11-08 | — | — | US | disclosed |
| US-9944925-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. | 2018-04-17 | — | — | US | disclosed |
| US-9422207-B2 | Compounds and methods for the production of long chain hydrocarbons from biological sources | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2016-08-23 | — | — | US | disclosed |
| US-9422207-B2 | Compounds and methods for the production of long chain hydrocarbons from biological sources | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2016-08-23 | — | — | US | disclosed |
| US-20160186168-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20150232394-A1 | COMPOUNDS AND METHODS FOR THE PRODUCTION OF LONG CHAIN HYDROCARBONS FROM BIOLOGICAL SOURCES | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2015-08-20 | — | — | US | disclosed |
| US-20150232394-A1 | COMPOUNDS AND METHODS FOR THE PRODUCTION OF LONG CHAIN HYDROCARBONS FROM BIOLOGICAL SOURCES | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2015-08-20 | — | — | US | disclosed |
| WO-2013040311-A1 | COMPOUNDS AND METHODS FOR THE PRODUCTION OF LONG CHAIN HYDROCARBONS FROM BIOLOGICAL SOURCES | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2013-03-21 | — | — | WO | disclosed |
| EP-1061090-A1 | Reduction of oligomer and gel formation in polyolefins | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2000-12-20 | — | — | EP | disclosed |
| WO-1998020045-A1 | REDUCTION OF FOULING IN OLEFIN POLYMERIZATION SYSTEMS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1998-05-14 | — | — | WO | disclosed |
| EP-0630910-A1 | Use of Lewis Bases for activity reduction in metallocene catalyzed olefin polymerization reactions | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1994-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232394-A1 | COMPOUNDS AND METHODS FOR THE PRODUCTION OF LONG CHAIN HYDROCARBONS FROM BIOLOGICAL SOURCES | HSD17B12, AKR1C4, FASN | ALDH1A1 489/4885LMNA 891/4885SLC15A2 4398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.